Dorfin inhibitors are a class of small molecules that have garnered significant attention in the field of molecular biology and biochemistry due to their unique ability to modulate cellular processes by targeting a specific protein called Dorfin. Dorfin is a ubiquitin ligase, an enzyme responsible for tagging proteins with ubiquitin molecules, thus marking them for degradation by the proteasome, a cellular machinery responsible for protein turnover. Dorfin plays a crucial role in maintaining protein homeostasis by facilitating the removal of misfolded or damaged proteins. However, when Dorfin becomes dysregulated or overactive, it can lead to aberrant protein degradation and contribute to the development of various neurodegenerative diseases, including Parkinson's and Alzheimer's.
Dorfin inhibitors are designed to interact with the Dorfin protein, disrupting its enzymatic activity and preventing it from ubiquitinating target proteins. By doing so, these inhibitors offer a means of regulating protein degradation within cells and potentially restoring protein homeostasis. The development of Dorfin inhibitors has opened up new avenues for research in understanding the molecular mechanisms underlying neurodegenerative diseases and protein aggregation disorders. Furthermore, these inhibitors have the potential to serve as valuable tools in elucidating the broader cellular pathways involved in protein quality control and degradation, paving the way for innovative strategies to combat diseases associated with protein misfolding and accumulation. The study and development of Dorfin inhibitors represent a promising area of research in the quest to decipher the intricate mechanisms governing cellular protein quality control.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A peptide aldehyde that inhibits proteasome activity, indirectly preventing the degradation of proteins ubiquitinated by Dorfin. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
A selective and irreversible proteasome inhibitor, affecting the pathway in which Dorfin is involved. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A boronic acid derivative that inhibits the 26S proteasome, thereby influencing the activity of Dorfin. | ||||||
Carfilzomib | 868540-17-4 | sc-396755 | 5 mg | $41.00 | ||
An epoxyketone-based proteasome inhibitor that can affect the ubiquitin-proteasome system involving Dorfin. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
An inhibitor of NEDD8-activating enzyme, interfering with the neddylation process, which is essential for ubiquitin ligase activity of Dorfin. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
An inhibitor of ubiquitin-activating enzyme E1, upstream in the ubiquitination pathway where Dorfin acts. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
A naturally occurring inhibitor of the proteasome, which would inhibit the degradation of proteins tagged by Dorfin. | ||||||
Oprozomib | 935888-69-0 | sc-477447 | 2.5 mg | $280.00 | ||
An orally bioavailable proteasome inhibitor that can modify the activity of the ubiquitin-proteasome system involving Dorfin. | ||||||